Literature DB >> 10051489

Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures.

J J Ventura1, C Roncero, I Fabregat, M Benito.   

Abstract

The effect of dexamethasone on Jun N-terminal kinase (JNK) activity was assayed by using fetal hepatocytes in primary culture. The addition of tumor necrosis factor alpha (TNF-alpha) caused an increase in JNK in a dose- and time-dependent manner. We show that activation of JNK by this extracellular signal is inhibited by dexamethasone in a dose-dependent fashion. This inhibitory effect was observed in cells treated for 10 minutes with dexamethasone in the presence of protein phosphatase inhibitors such as orthovanadate or okadaic acid, or in cells previously treated with actinomycin D. Glucocorticoid receptor (GR) can be precipitated with the fusion protein, GST-c-Jun (1-79), bound to agarose beads. However, the inhibitory effect of glucocorticoids on JNK activity was also observed using ATF-2 as substrate. In addition, dexamethasone inhibits JNK phosphorylation induced by TNF-alpha. Finally, we show that GR can also be phosphorylated in tyrosine residues in response to TNF-alpha and epidermal growth factor (EGF) upon ligand-binding. Our results suggest that the anti-inflammatory effect of glucocorticoids on the inflammatory pathways induced by TNF-alpha can be explained, at least in part, by modulating JNK activity through a direct protein-protein interaction; the JNK phosphorylation and tyrosine-phosphorylation state of GR may be regulatory steps also involved in that effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051489     DOI: 10.1002/hep.510290339

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

Review 1.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

2.  Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.

Authors:  Alejandra Bruna; Marta Nicolàs; Alberto Muñoz; John M Kyriakis; Carme Caelles
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

3.  Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.

Authors:  Marina Lasa; Sonya M Abraham; Christine Boucheron; Jeremy Saklatvala; Andrew R Clark
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  Glucocorticoids antagonize AP-1 by inhibiting the Activation/phosphorylation of JNK without affecting its subcellular distribution.

Authors:  M V González; B Jiménez; M T Berciano; J M González-Sancho; C Caelles; M Lafarga; A Muñoz
Journal:  J Cell Biol       Date:  2000-09-04       Impact factor: 10.539

5.  The osmoregulatory and the amino acid-regulated responses of system A are mediated by different signal transduction pathways.

Authors:  Marta López-Fontanals; Silvia Rodríguez-Mulero; F Javier Casado; Benoit Dérijard; Marçal Pastor-Anglada
Journal:  J Gen Physiol       Date:  2003-06-16       Impact factor: 4.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.